Abeona Therapeutics (ABEO) Research & Development (2011 - 2026)

Abeona Therapeutics' Research & Development history runs 16 years deep, the most recent figure standing at $9.6 million for Q1 2026.

• In Q1 2026, Research & Development fell 3.88% year-over-year to $9.6 million; the TTM figure through Mar 2026 stood at $26.4 million (down 28.76% YoY), while the FY2025 annual figure was $26.8 million, down 21.97% from the prior year.
• Research & Development was $9.6 million for Q1 2026 at Abeona Therapeutics, up from $6.7 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $10.5 million in Q1 2022 to a low of $4.2 million in Q3 2025.
• Historically, Research & Development has averaged $7.7 million across 5 years, with a median of $7.4 million in 2023.
• Biggest YoY gain for Research & Development was 37.94% in 2025; the steepest drop was 52.85% in 2025.
• A 5-year view of Research & Development shows it stood at $6.3 million in 2022, then rose by 17.65% to $7.4 million in 2023, then grew by 21.89% to $9.0 million in 2024, then retreated by 25.37% to $6.7 million in 2025, then soared by 42.36% to $9.6 million in 2026.
• The last three Research & Development figures came in at $9.6 million (Q1 2026), $6.7 million (Q4 2025), and $4.2 million (Q3 2025), per Business Quant data.